A 67-Year-Old Woman With Knee Pain Cmaj
A 67-Year-Old Woman With Knee Pain Cmaj
CME
CMAJ
Decisions
© 2014 Canadian Medical Association or its licensors CMAJ, November 18, 2014, 186(17) 1311
Practice
acetaminophen as a first-line agent for mild to Although some older systematic reviews sug-
moderate arthritis. Because of reports of gastroin- gested minor benefits for the use of physical
testinal adverse events, elevated hepatic enzymes modalities or were inconclusive,3,4 more recent
and overdose, the OARSI guideline recommends randomized trials showed no additional benefits
conservative dosing and treatment duration of to the use of these modalities.4 Manual therapy
acetaminophen.4 Although the OARSI guideline received an inconclusive rating in the AAOS
does not give exact parameters on this recom- guideline based on a lack of adequate studies
mendation, the AAOS guideline indicates it may evaluating joint mobilization, joint manipulation,
be prudent to restrict the over-the-counter dose of chiropractic therapy, patellar mobilization or
acetaminophen to 3000 mg per day and reserve myofascial release.3
the 4000 mg per day dose for prescriptions.3 In a Cochrane review, use of opioids for hip
Second-line agents include oral and topical non- and knee arthritis was found to be effective for
steroidal anti-inflammatory drugs (NSAIDs), selec- pain control and improvement in physical func-
tive cyclooxygenase-2 inhibitors and topical capsa- tion; however, because of a high rate of adverse
icin.6 Use of oral and topical NSAIDs received a events, the authors did not recommend the routine
strong recommendation in the AAOS guideline.3 use of opioids for the treatment of osteoarthritis.8
For patients with osteoarthritis localized to Most articles in this review combined data on hip
one or both knees, the OARSI guideline recom- and knee osteoarthritis. The AAOS group found
mends the use of local medications, including no studies on opioids or pain patches for the treat-
topical NSAIDs and corticosteroid injections ment of knee osteoarthritis that met its inclusion
(see below).4 This was especially emphasized in criteria, and the group was unable to recommend
patients with coexisting medical comorbidities, for or against opioid use.3 Other guideline groups
which are very common in this patient popula- were also unable to make a recommendation
tion.4 Each medication carries unique safety and regarding opioid use.4,6
adverse-effect profiles, and therapies should be Medial compartment–unloading braces
specific to each patient’s individual risk factors received an inconclusive recommendation from
and medical comorbidities. the AAOS;3 however, this intervention was sup-
ported by OARSI.4 The evidence for their use
If initial treatment fails, what other appears to be inconsistent. The AAOS recom-
options may be considered? mendation was based on inconsistent findings
Several options may be considered when initial from three moderate- to high-quality RCTs, with
treatment does not result in satisfactory symptom improvement in pain scores not always reaching
control. These include systemic medications statistical significance.3
(e.g., tramadol, duloxetine, opioids), intra-articular With inconclusive or uncertain recommenda-
corticosteroid injections, medial compartment– tions, both the AAOS and OARSI guidelines
unloading braces, physical modalities and man- stress that clinical judgment and patient prefer-
ual therapy. ence should have a substantial influencing role
For refractory symptoms, guidelines recom- when deciding to use these treatment modalities
mend tramadol3,4,6 and duloxetine.4,6 The AAOS for the management of knee osteoarthritis.3,4
recommendation for the use of tramadol is on the
basis of five RCTs that showed outcomes in What treatments shouldn’t be offered?
favour of the treatment group.3 Duloxetine is rec- There are many other treatments that have been
ommended by OARSI on the basis of a system- used for osteoarthritis, including needle lavage
atic review and an RCT that showed that the drug for joints, lateral wedge insoles, acupuncture,
is efficacious and well tolerated for chronic pain glucosamine, chondroitin, intra-articular injec-
associated with knee osteoarthritis.4 Whereas the tions of hyaluronic acid, and arthroscopy. How-
use of intra-articular corticosteroid injections was ever, studies of these treatments have not con
deemed inconclusive in the AAOS guideline,3 the siste ntly shown statistically significant or
OARSI guideline supports their use because of clinically important improvements, and their use
two systematic reviews showing significant short- is not routinely recommended in guidelines.
term decreases in pain.4 Needle lavage for joints was assessed in a
The use of physical modalities (e.g., transcu- 2010 Cochrane review, and the authors found no
taneous electrical nerve stimulation, ultrasound, benefit in terms of pain relief or improvement in
therapeutic application of musically modulated physical function.9 Neither the EULAR nor the
electromagnetic fields) and manual therapy all AAOS guidelines recommend using lateral
received an inconclusive recommendation from wedge insoles because of lack of efficacy in com-
the AAOS work group.3 These recommendations parison to neutral insoles3,5 and reports of adverse
are supported by several other guidelines.4,6 events.5 A recent meta-analysis investigating the
use of lateral wedge insoles for treatment of effects with use of hyaluronic acid injections;
medial knee osteoarthritis failed to show a statis- however, none of the improvements met the
tically significant or clinically important AAOS group’s threshold for minimal clinically
improvement in pain scores using the Western important improvement.3 The OARSI’s uncer-
Ontario and McMaster Universities Osteoarthritis tain recommendation was based on two system-
Index (WOMAC) when compared with a neutral atic reviews and an RCT that provided inconsis-
insole.10 The Canadian Orthopaedic Association, tent conclusions and conflicting results.4
as part of the Choosing Wisely Canada cam- Over the past decade, there has been increasing
paign, does not recommend the use of either joint evidence against the use of arthroscopy in the
lavage or lateral wedge insoles for the treatment management of knee osteoarthritis. The current
of knee arthritis11 (Box 1). AAOS guideline reflects this and strongly recom-
The AAOS guideline recommends against the mends against the use of arthroscopy in the man-
use of acupuncture, glucosamine, chondroitin agement of knee osteoarthritis.3 This recommenda-
and hyaluronic acid injections for the manage- tion was based on three RCTs (two with moderate
ment of osteoarthritis of the knee.3 Other guide- strength and one with strong strength) that failed to
lines, including the 2014 OARSI guideline, are show any clinical benefit, as well as on the risk
less critical of these modalities; however, they associated with surgical intervention.3 This recom-
also do not recommend their use.4,6 mendation did not apply to patients with a primary
Acupuncture is not recommended by the diagnosis of meniscal tear and concomitant knee
AAOS based on 10 studies (five high strength osteoarthritis. In this patient population, the AAOS
and five moderate strength), most of which did found insufficient evidence to recommend for or
not show statistically significant improvement, against arthroscopic partial meniscectomy and ren-
and if they did show improvement, it was not dered an inconclusive recommendation.3
clinically significant.3 The uncertain recommen-
dation in the OARSI guideline on acupuncture The case
was based on a meta-analysis that found statis Plain radiography confirmed the diagnosis of
tically significant, but not clinically significant, moderate osteoarthritis of the knees. The patient
benefit in sham-controlled trials.4 was referred to a self-management program
Like the AAOS, the Canadian Orthopaedic through The Arthritis Society (www.arthritis.ca/
Association, as part of the Choosing Wisely asmp) for control of her knee osteoarthritis. As an
Canada campaign, recommends against the use initial management plan, a low-impact exercise
of glucosamine or chondroitin in patients with program, a weight-loss plan that included both
symptomatic osteoarthritis of the knee (Box 1). diet and exercise, and an acetaminophen dose of
The AAOS group based its recommendation on 500 mg every 6 hours as required was recom-
the analysis of 5 high-quality, 1 low-quality and mended. Should the initial management plan fail
15 moderate-quality studies, which failed to to provide sufficient symptomatic relief, a topical
show improvement in pain and function scores NSAID would be a safe and generally effective
using WOMAC and pain scores using a visual addition, taking into consideration that the patient
analogue scale.3 The OARSI guideline was less
critical than the AAOS guideline, but more spe-
cific. The OARSI guideline indicates that glu- Box 1: Choosing Wisely Canada recommendations*
cosamine and chondroitin are not appropriate for Don’t use needle lavage to treat symptomatic osteoarthritis of the knee
use in knee osteoarthritis as disease-modifying for long-term relief.
agents and, partly because of inconsistencies in • The use of needle lavage in patients with symptomatic osteoarthritis
results between industry-sponsored and indepen- of the knee does not lead to measurable improvements in pain,
dent trials, was uncertain about their role in pain function, 50-foot walking time, stiffness, tenderness or swelling.
relief.4 An older Cochrane review on the use of Don’t use glucosamine and chondroitin to treat symptomatic osteoarthritis
glucosamine in osteoarthritis showed that its use, of the knee.
when restricted to analysis of studies with ade- • Both glucosamine and chondroitin sulfate do not provide relief for
patients with symptomatic osteoarthritis of the knee.
quate allocation concealment and not using a
Don’t use lateral wedge insoles to treat symptomatic medial compartment
specific brand, failed to show a benefit in
osteoarthritis of the knee.
WOMAC pain or function scores.12
• In patients with symptomatic osteoarthritis of the knee, the use of
The AAOS group based its recommendation lateral wedge or neutral insoles does not improve pain or functional
on intra-articular hyaluronic acid injections on outcomes. In addition, the possibility exists that those who do not use
14 studies (3 high-strength and 11 moderate- them may experience fewer symptoms from osteoarthritis of the knee.
strength studies). Meta-analyses of pain, func- *Source: Canadian Orthopaedic Association: Five things physicians and patients should
tion and stiffness scores using WOMAC sub- question. Choosing Wisely Canada; 2014. Available: www.choosingwiselycanada.org/
recommendations/canadian-orthopaedic-association-2.
scales all found statistically significant treatment
REPRINTS
l 39 N
5 P
89 60
da
le du Cana
cine rura 4
de la méde E 201
Société TOMN
el de la 4, AU
al offici 19, Nº
VO
Le journ
MÉ LUME RO
S
CE NU
da
of Cana
icians
l Phys
DANS
b
of Rura
Society 4
al of the L 201 s
ancie
14
al journ . 4, FAL
The offici 19, NO pregn
VOLU
ME
d he althy SM l
SUE .ca NO journa pulation
IS IS ives an
jpn
ulum
ricn-a
cceatss
ns po
IN TH midw An ope Natio
Inuit healt
h cur First ber 5
ginal in a block 39 Num
Abori eumo
nia nerve ume
ired pn Sep 2014 Vol
ipital icits
-acqu r occber
atetem bal def
unity al gre and ver
asion F804A)
Comm 804A (ZN
The occ er protein ism
Zinc fing uals with aut eptor–
ivid coid rec the
in ind cocorti s for
es a glu implication
137 regulat wor k:
NA- net
MicroR alling
ent sign nia ctrum
depend of schizophre nia-spe
izophre ation of 2014
y 4, August/août
etiolog in sch stig s Vol. 57, No. canjsurg.ca
deficits An inve and drug cue
cessing nabis use? s
ard-pro reward
Do rew rs promote can to natural
se
disorde respon
ogical
res in children
lar elbow fractu
me of supracondy
f
CMAJ•JAMC
WWW.CMAJ.CA
of cast mate RCT
Comparison od: a prospective
the Ponseti meth
with operative
res associated
uted tomo graphy featu bowe l obstruction
Comp lating small
for nonstrangu
RESEARCH
The validity of recommendations
from clinical guidelines
GUIDELINES
Matt Neiderer
Recommendations on screening
for prostate cancer
PRACTICE
Prednisone and infection risk
in an older male patient